Latest filing published 11 Dec 2023 for DermTech, Inc., €203. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Claudia Ibarra in DermTech, Inc., where the filings describe the role as chief executive. In total, 21 filings cover trades dated from 8 June 2021 to 7 December 2023.
Sales make up the whole of the open-market record (20 sales, €320k). Other entries cover 1 share grant. Since January 2023: no purchases and 6 sales on the market.
The newest entry dates from 11 December 2023: an open-market sale of €203, in DermTech, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations